GLSHQ (Gelesis Holdings) Total Assets: $95.88 Mil (As of Jun. 2023)


What is Gelesis Holdings Total Assets?

Gelesis Holdings GLSHQ -99.00% Total Assets is $95.88 Mil as of Jun. 2023.

Gelesis Holdings's Total Assets for the quarter that ended in Jun. 2023 was $95.88 Mil.

Total Assets is connected with ROA %. Gelesis Holdings's annualized ROA % for the quarter that ended in Jun. 2023 was -31.57%. Total Assets is also linked to Revenue through Asset Turnover. Gelesis Holdings's Asset Turnover for the quarter that ended in Jun. 2023 was 0.01.

Gelesis Holdings  (OTCPK:GLSHQ) Total Assets Explanation

Total Assets is connected with ROA %.

Gelesis Holdings's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %=Net Income (Q: Jun. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Jun. 2023 ))/ count )
=-30.724/( (98.78+95.875)/ 2 )
=-30.724/97.3275
=-31.57 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Gelesis Holdings's Asset Turnover for the quarter that ended in Jun. 2023 is

Asset Turnover
=Revenue (Q: Jun. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Jun. 2023 ))/ count )
=1.107/( (98.78+95.875)/ 2 )
=1.107/97.3275
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Gelesis Holdings Total Assets Related Terms

Gelesis Holdings Total Assets Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings Total Assets Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Total Assets
146.30 103.32

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 138.97 130.52 103.32 98.78 95.88

Gelesis Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Gelesis Holdings's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets=Total Equity (A: Dec. 2022 )+Total Liabilities (A: Dec. 2022 )
=-12.466+115.79
=103.32

Gelesis Holdings's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets=Total Equity (Q: Jun. 2023 )+Total Liabilities (Q: Jun. 2023 )
=-18.625+114.5
=95.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $95.88 Mil mean?
Gelesis Holdings (GLSHQ) has a Total Assets of $95.88 Mil as of Jun. 2023. The total amount of assets as recorded on a company's balance sheet. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' Total Assets too high?
Gelesis Holdings' current Total Assets is $95.88 Mil.
How does Gelesis Holdings' Total Assets compare to RBSH and PPCB?
Gelesis Holdings' Total Assets of $95.88 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current Total Assets is $95.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current Total Assets of $95.88 Mil. The current Total Assets is $95.88 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current Total Assets is $95.88 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.